These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38558097)

  • 21. Antazoline for pharmacologic cardioversion of atrial fibrillation: teaching an old drug new tricks.
    Lip GYH; Mills MT
    Pol Arch Intern Med; 2024 Apr; 134(4):. PubMed ID: 38666721
    [No Abstract]   [Full Text] [Related]  

  • 22. Giant P waves after pharmacological cardioversion of atrial fibrillation.
    Catapano-Minotti G; Corsonello A; Antonelli Incalzi R
    Intern Emerg Med; 2009 Apr; 4(2):169-70. PubMed ID: 19050836
    [No Abstract]   [Full Text] [Related]  

  • 23. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
    Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
    N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD
    Expert Opin Investig Drugs; 2008 May; 17(5):805-10. PubMed ID: 18447605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
    Anderson ME
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid cardioversion of new onset atrial fibrillation with ibutilide in the emergency department.
    Ryan DT; Cummins FH; Fahy GJ
    Ir Med J; 2005 Sep; 98(8):241-2. PubMed ID: 16255117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical cardioversion of atrial fibrillation with intravenous dofetilide.
    Sedgwick ML; Lip G; Rae AP; Cobbe SM
    Int J Cardiol; 1995 Apr; 49(2):159-66. PubMed ID: 7628887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation: choosing an antiarrhythmic drug.
    Rudo T; Kowey P
    Curr Cardiol Rep; 2006 Sep; 8(5):370-6. PubMed ID: 16956453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation.
    Nattel S
    J Physiol; 2009 Apr; 587(Pt 7):1385-6. PubMed ID: 19336611
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel molecular targets for atrial fibrillation therapy.
    Dobrev D; Carlsson L; Nattel S
    Nat Rev Drug Discov; 2012 Mar; 11(4):275-91. PubMed ID: 22460122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.
    McBride BF
    J Clin Pharmacol; 2009 Mar; 49(3):258-67. PubMed ID: 19246727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department in the Novel Anticoagulants' Era.
    Tsiachris D; Doundoulakis I; Tsioufis K
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1253-1254. PubMed ID: 35218470
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis.
    Tsiachris D; Doundoulakis I; Pagkalidou E; Kordalis A; Deftereos S; Gatzoulis KA; Tsioufis K; Stefanadis C
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):293-308. PubMed ID: 33400054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial-selective sodium channel block for the treatment of atrial fibrillation.
    Burashnikov A; Antzelevitch C
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):233-49. PubMed ID: 19466903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological cardioversion of recent onset atrial fibrillation.
    Khan IA
    Eur Heart J; 2004 Aug; 25(15):1274-6. PubMed ID: 15288151
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiarrhythmic Drug Therapy for Atrial Fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Heart Fail Clin; 2016 Apr; 12(2):205-21. PubMed ID: 26968666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic relevance of K(+)Channel remodeling in atrial fibrillation.
    Van Wagoner DR
    J Mol Cell Cardiol; 2000 Oct; 32(10):1763-6. PubMed ID: 11013120
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.